Search Results
Displaying 841 - 850 of 1275
… block NCT: NCT05025787 Status: Completed Sites: For more information, visit Enrolling sites Principal Investigator: … Manager jennifer.barnes@nih.gov Kevin T. Jones, Ph.D. Health Program Specialist joneskt@nih.gov eRA Contact Laura … EPPIC-Net OTA Review Committee Roster NIH Policies HEAL Public Access and Data Sharing NIH Shared Policies and …
… and effective therapies. NINDS is also working with its public and private partners to advance genomic therapy for … . In May, the Foundation for the National Institutes of Health (FNIH) , which manages the AMP BGTC program, announced … for gene editing, and 2) the means to cross the blood brain barrier, which is a significant hurdle to overcome when …
… neurological disorders. Contact smriti.iyengar@nih.gov +1 301 496 1779 Smriti Iyengar, Ph.D., is Program Director for …
… Amyotrophic lateral sclerosis (ALS) is a progressive and ultimately fatal neurodegenerative disorder that affects … fluid (CSF) the fluid that surrounds and protects the brain and spinal cord. These and other results suggest that … PMID: 31866818 ; PMCID: PMC6909825. (Australia, public and private sources) Berdyński M, Miszta P, Safranow …
… ) Georgia Emory University Title: Training in System and Integrative Biology Neuroscience Program Director: Yoland … ) New York Columbia University Title: Neurobiology and Behavioral Training Grant Program Director: Wesley … James Herman Ph.D. ( james.herman@uc.edu ) Oregon Oregon Health & Science University Title: Multidisciplinary Training …
… While the long-term consequences of hypertension on the brain’s vasculature are well-studied, Dr. Iadecola has worked … perivascular macrophages mediate neurovascular dysfunction and cognitive declines induced by hypertension. … …
… research training to prepare advanced predoctoral (years 3 and 4) and/or postdoctoral trainees to have a successful … Eligibility U.S. domestic institutions Additional Information The objective of this NINDS Institutional AD/ADRD … exceptions are possible and will require that additional information be provided for administrative review and prior …
… Staff Scientist and Core Director, Drug Development Unit, Translational … for identified targets for drug development using primary brain cells or stem cell derived neuronal and glial cells. … …
Amy Bany Adams, Ph.D. Acting Director of NINDS
… continuum to focus on the effect of external, internal, and behavioral risk factors on neurological health. The concept of the "exposome", coined in 2005, … includes all exogenous (e.g., environmental toxicants and climate), endogenous (e.g., microbiome and epigenetic …